Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Medical cannabis-related stigma: cancer survivors’ perspectives

Medical cannabis-related stigma: cancer survivors’ perspectives

Thumbnail Image
Download
Name

11764_2022_Article_1297.pdf

Size

577.43 KB

Format

Adobe PDF

Checksum (MD5)

1fcfd0e2b8372aba84ecc23f69ee712b

Download all files submitted through automated deposit
art_1382509855769290152.zip (463.84 KB)
Author(s)
Nayak, Manan M.
•
Revette, Anna
•
Chai, Peter R.
•
Lansang, Kristina
•
Sannes, Timothy
•
Tung, Stephanie
•
Braun, Ilana M.
Date Issued
November 26, 2022
Publisher
Springer US
Citation
Nayak, Manan M., Revette, Anna, Chai, Peter R., Lansang, Kristina, Sannes, Timothy et al. 2022. "Medical cannabis-related stigma: cancer survivors’ perspectives."
Version
Final published version
Abstract
Abstract Background Although the vast majority of medical cannabis laws in the USA includes cancer as a qualifying condition and medical cannabis-related stigma influences decision-making regarding the botanical, few studies have explored the phenomenon in oncology. Early findings indicated oncologic cannabis-related stigma to be quite widespread. Methods Semi-structured interviews with 24 adults with cancer histories using medical cannabis were analyzed using the Health Stigma and Discrimination Framework. Results Sixteen out of 24 participants discussed medical cannabis-related stigma in some depth. The phenomena emerged as more pervasive in medical than personal/professional domains and was internalized as well as experienced directly. It led some participants, but not others, to practice partial or complete secrecy. Discussion Taken together, our findings suggest that, while medical cannabis-related stigma remains widespread and led some study participants to alter behavior, an early shift in ethos towards greater medical cannabis acceptance could be underway. If so, this transition may be occurring more rapidly in non-medical than in clinical settings. Conclusion Cancer survivors may experience heightened medical cannabis-related stigma in the clinic as compared to their personal/professional lives. Healthcare providers who depend on patient transparency when gathering medical histories and devising care plans may wish to neutralize perceptions of medical cannabis-related stigma.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/146627
DOI of Published Version
https://doi.org/10.1007/s11764-022-01297-7
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.